» Articles » PMID: 35140205

Dynamic Runx1 Chromatin Boundaries Affect Gene Expression in Hematopoietic Development

Abstract

The transcription factor RUNX1 is a critical regulator of developmental hematopoiesis and is frequently disrupted in leukemia. Runx1 is a large, complex gene that is expressed from two alternative promoters under the spatiotemporal control of multiple hematopoietic enhancers. To dissect the dynamic regulation of Runx1 in hematopoietic development, we analyzed its three-dimensional chromatin conformation in mouse embryonic stem cell (ESC) differentiation cultures. Runx1 resides in a 1.1 Mb topologically associating domain (TAD) demarcated by convergent CTCF motifs. As ESCs differentiate to mesoderm, chromatin accessibility, Runx1 enhancer-promoter (E-P) interactions, and CTCF-CTCF interactions increase in the TAD, along with initiation of Runx1 expression from the P2 promoter. Differentiation to hematopoietic progenitor cells is associated with the formation of tissue-specific sub-TADs over Runx1, a shift in E-P interactions, P1 promoter demethylation, and robust expression from both Runx1 promoters. Deletion of promoter-proximal CTCF sites at the sub-TAD boundaries has no obvious effects on E-P interactions but leads to partial loss of domain structure, mildly affects gene expression, and delays hematopoietic development. Together, our analysis of gene regulation at a large multi-promoter developmental gene reveals that dynamic sub-TAD chromatin boundaries play a role in establishing TAD structure and coordinated gene expression.

Citing Articles

CTCF is selectively required for maintaining chromatin accessibility and gene expression in human erythropoiesis.

Yang X, Cheng L, Xin Y, Zhang J, Chen X, Xu J Genome Biol. 2025; 26(1):44.

PMID: 40022213 PMC: 11869676. DOI: 10.1186/s13059-025-03510-z.


TAD-dependent sub-TAD is required for enhancer-promoter interaction enabling the β-globin transcription.

Lee D, Kang J, Kim A FASEB J. 2024; 38(22):e70181.

PMID: 39545685 PMC: 11698014. DOI: 10.1096/fj.202401526RR.


Spectral-based detection of chromatin loops in multiplexed super-resolution FISH data.

Liefsoens M, Foldes T, Barbi M Nat Commun. 2024; 15(1):7670.

PMID: 39237524 PMC: 11377450. DOI: 10.1038/s41467-024-51650-w.


Inhibition of RUNX1 slows the progression of pulmonary hypertension by targeting CBX5.

Ma X, Cao Y, Yang D, Dong Z, Wang X Biomol Biomed. 2024; 25(2):472-481.

PMID: 39151099 PMC: 11734815. DOI: 10.17305/bb.2024.10720.


Huntingtin is an RNA binding protein and participates in -mediated paraspeckles.

Yadav M, Harding R, Li T, Xu X, Gall-Duncan T, Khan M Sci Adv. 2024; 10(29):eado5264.

PMID: 39028820 PMC: 11259171. DOI: 10.1126/sciadv.ado5264.


References
1.
de Bruijn M, Dzierzak E . Runx transcription factors in the development and function of the definitive hematopoietic system. Blood. 2017; 129(15):2061-2069. DOI: 10.1182/blood-2016-12-689109. View

2.
Levanon D, Groner Y . Structure and regulated expression of mammalian RUNX genes. Oncogene. 2004; 23(24):4211-9. DOI: 10.1038/sj.onc.1207670. View

3.
Gao L, Tober J, Gao P, Chen C, Tan K, Speck N . RUNX1 and the endothelial origin of blood. Exp Hematol. 2018; 68:2-9. PMC: 6494457. DOI: 10.1016/j.exphem.2018.10.009. View

4.
Yzaguirre A, de Bruijn M, Speck N . The Role of Runx1 in Embryonic Blood Cell Formation. Adv Exp Med Biol. 2017; 962:47-64. PMC: 5813695. DOI: 10.1007/978-981-10-3233-2_4. View

5.
Sood R, Kamikubo Y, Liu P . Role of RUNX1 in hematological malignancies. Blood. 2017; 129(15):2070-2082. PMC: 5391618. DOI: 10.1182/blood-2016-10-687830. View